Company profile
Lexeo Therapeutics, Inc. Insider Trading
LXEOEvery SEC Form 4 insider trading filing for Lexeo Therapeutics, Inc. (LXEO) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001907108
- Filings
- 96
- Insiders
- 28
- Last filing
- 2026-08-18
Activity summary
No insider transactions in the last 30 days. The most recent was on August 18, 2026, when Louis Edward Tamayo sold 4,117 shares. 96 filings from 28 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Lexeo Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $12.5M.
90 day insight
Over the last 90 days, Lexeo Therapeutics, Inc. insiders bought $0 (4 transactions) and sold $300K (7 transactions).
- Most active insider: Richard Nolan Townsend with 3 transactions totaling $133K.
- Largest single sale: $116K by Richard Nolan Townsend on Jul 1, 2026.
Activity skews bearish: sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Louis Edward Tamayo | LXEO | Sale | 4,117 | $4.91 | $20K |
| Aug 18, 2026 | Richard Nolan Townsend | LXEO | Sale | 3,345 | $4.95 | $17K |
| Aug 18, 2026 | Jose Manuel Otero | LXEO | Sale | 1,304 | $4.96 | $6K |
| Jul 1, 2026 | Richard Nolan Townsend | LXEO | Sale | 25,947 | $4.48 | $116K |
| Jul 1, 2026 | Narinder Pal Bhalla | LXEO | Sale | 22,306 | $4.42 | $99K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=LXEO" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Lexeo Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →